Emerging role of electrochemistry in radiochemical separation of medically important radiometals: state of the art.

IF 2 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING American journal of nuclear medicine and molecular imaging Pub Date : 2024-10-15 eCollection Date: 2024-01-01 DOI:10.62347/XITW6701
Sourav Patra, Sudipta Chakraborty, Rubel Chakravarty
{"title":"Emerging role of electrochemistry in radiochemical separation of medically important radiometals: state of the art.","authors":"Sourav Patra, Sudipta Chakraborty, Rubel Chakravarty","doi":"10.62347/XITW6701","DOIUrl":null,"url":null,"abstract":"<p><p>Electrochemical separation technology has brought a renaissance in the field of nuclear medicine towards obtaining clinical-grade radiometals for preparation of a wide variety of radiopharmaceuticals. This article is a comprehensive summary of the electrochemical processes developed for the separation of radiometals that could be used for diagnostic or therapeutic applications in nuclear medicine. For using electrochemistry as a tool for the separation of radiometals, intricate knowledge is essential to understand the basic parameters of electrochemical separation processes which include applied potential, selection of electrolyte, choice of the electrode, the temperature of the electrolyte, pH of the electrolyte and time of electrolysis. The advantages of the electrochemical separation approach over the other conventional methodologies such as solvent extraction, column chromatography, sublimation, etc., have also been discussed. The latest research and development from our laboratory on electrochemical methodologies developed for separation of <sup>90</sup>Y from <sup>90</sup>Sr, <sup>188</sup>Re from <sup>188</sup>W, <sup>99m</sup>Tc from <sup>99</sup>Mo, <sup>47</sup>Sc from <sup>46</sup>Ca, <sup>45</sup>Ca from <sup>46</sup>Sc,<sup>153</sup>Sm from <sup>154</sup>Eu, <sup>169</sup>Er from <sup>169</sup>Yb, <sup>177</sup>Lu from Yb and <sup>132/135</sup>La from Ba have been described. In all the cases, the final product is obtained either in a 'no-carrier-added' (NCA) form or free from inextricable impurities and thus found suitable for formulation of radiopharmaceuticals.</p>","PeriodicalId":7572,"journal":{"name":"American journal of nuclear medicine and molecular imaging","volume":"14 5","pages":"282-294"},"PeriodicalIF":2.0000,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11578814/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of nuclear medicine and molecular imaging","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.62347/XITW6701","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0

Abstract

Electrochemical separation technology has brought a renaissance in the field of nuclear medicine towards obtaining clinical-grade radiometals for preparation of a wide variety of radiopharmaceuticals. This article is a comprehensive summary of the electrochemical processes developed for the separation of radiometals that could be used for diagnostic or therapeutic applications in nuclear medicine. For using electrochemistry as a tool for the separation of radiometals, intricate knowledge is essential to understand the basic parameters of electrochemical separation processes which include applied potential, selection of electrolyte, choice of the electrode, the temperature of the electrolyte, pH of the electrolyte and time of electrolysis. The advantages of the electrochemical separation approach over the other conventional methodologies such as solvent extraction, column chromatography, sublimation, etc., have also been discussed. The latest research and development from our laboratory on electrochemical methodologies developed for separation of 90Y from 90Sr, 188Re from 188W, 99mTc from 99Mo, 47Sc from 46Ca, 45Ca from 46Sc,153Sm from 154Eu, 169Er from 169Yb, 177Lu from Yb and 132/135La from Ba have been described. In all the cases, the final product is obtained either in a 'no-carrier-added' (NCA) form or free from inextricable impurities and thus found suitable for formulation of radiopharmaceuticals.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
电化学在重要医用放射性金属的放射化学分离中的新作用:最新技术。
电化学分离技术为核医学领域带来了一场复兴,旨在获得临床级放射性金属,用于制备各种放射性药物。本文全面总结了为分离可用于核医学诊断或治疗的放射性金属而开发的电化学过程。要利用电化学作为分离放射性金属的工具,了解电化学分离过程的基本参数至关重要,这些参数包括应用电位、电解质的选择、电极的选择、电解质的温度、电解质的 pH 值和电解时间。此外,还讨论了电化学分离方法相对于其他传统方法(如溶剂萃取、柱层析、升华等)的优势。此外,还介绍了我们实验室最新研发的电化学方法,用于从 90Sr 中分离 90Y、从 188W 中分离 188Re、从 99Mo 中分离 99mTc、从 46Ca 中分离 47Sc、从 46Sc 中分离 45Ca、从 154Eu 中分离 153Sm、从 169Yb 中分离 169Er、从 Yb 中分离 177Lu 以及从 Ba 中分离 132/135La。在所有这些案例中,最终产品都是以 "无载体添加"(NCA)的形式或不含杂质的形式获得的,因此适用于配制放射性药物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
American journal of nuclear medicine and molecular imaging
American journal of nuclear medicine and molecular imaging RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING-
自引率
4.00%
发文量
4
期刊介绍: The scope of AJNMMI encompasses all areas of molecular imaging, including but not limited to: positron emission tomography (PET), single-photon emission computed tomography (SPECT), molecular magnetic resonance imaging, magnetic resonance spectroscopy, optical bioluminescence, optical fluorescence, targeted ultrasound, photoacoustic imaging, etc. AJNMMI welcomes original and review articles on both clinical investigation and preclinical research. Occasionally, special topic issues, short communications, editorials, and invited perspectives will also be published. Manuscripts, including figures and tables, must be original and not under consideration by another journal.
期刊最新文献
18F-FDG-PET and other imaging modalities in the diagnosis and management of inflammatory bowel disease. Emerging role of electrochemistry in radiochemical separation of medically important radiometals: state of the art. Evaluation of specific binding of [11C]TZ7774 to the receptor-interacting protein kinase 1 (RIPK1) in the brain. Investigating the shared genetic architecture of osteoarthritis and frailty: a genome-wide cross-trait analysis. Normal-organ distribution of PSMA-targeting PET radiopharmaceutical 18F-flotufolastat: a post hoc analysis of the LIGHTHOUSE and SPOTLIGHT studies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1